Treatment of type B insulin resistance: A novel approach to reduce insulin receptor autoantibodies

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 8, 2010, Pages 3641-3647

  Malek, Malek ^a   Chong, A Y ^a   Lupsa, B C ^a   Lungu, A O ^a   Cochran, E K ^a   Soos, M A ^b   Semple, R K ^b   Balow, J E ^a   Gorden, P ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; INSULIN RECEPTOR ANTIBODY; LIPID; MEPREDNISONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TESTOSTERONE;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; HYPERANDROGENISM; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN TREATMENT; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL; REMISSION; TREATMENT RESPONSE; TYPE B INSULIN RESISTANCE;

EID: 77955362834     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0167     Document Type: Article

References (27)

1. Arioglu E, Andewelt A, Diabo C, Bell M, Taylor SI, Gorden P 2002 Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective. Medicine (Baltimore) 81:87-100
2. Braund WJ, Naylor BA, Williamson DH, Buley ID, Clark A, Chapel HM, Turner RC 1987 Autoimmunity to insulin receptor and hypoglycaemia in patient with Hodgkin's disease. Lancet 1:237-240 (Pubitemid 17011180)
3. Chan JC, Zhu SQ, Ho SK, Cockram CS 1990 Hypoglycaemia and Hodgkin's disease. Br J Haematol 76:434-436
4. Gorden P, Collier E, Roach P 1993 Autoimmune mechanisms of insulin resistance and hypoglycemia. In: Moley DE, ed. Insulin resistance. London: John Wiley; 123-142
5. Sluss PM, Schneyer AL 1992 Low molecular weight follicle-stimulating hormone receptor binding inhibitor in sera from premature ovarian failure patients. J Clin Endocrinol Metab 74:1242-1246
6. Peter JC, Bekel A, Lecourt AC, Zipfel G, Eftekhari P, Nesslinger M, Breidert M, Muller S, Kessler L, Hofbauer KG 2009 Anti-melanocortin-4 receptor autoantibodies in obesity. J Clin Endocrinol Metab 94:793-800
7. Flier JS, Kahn CR, Jarrett DB, Roth J 1976 Characterization of antibodies to the insulin receptor: a cause of insulin-resistant diabetes in man. J Clin Invest 58:1442-1449
8. Flier JS, Kahn CR, Roth J, Bar RS 1975 Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science 190:63-65
9. Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, Roth J 1976 The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med 294:739-745
10. De Pirro R, Roth RA, Rossetti L, Goldfine ID 1984 Characterization of the serum from a patient with insulin resistance and hypoglycemia. Evidence for multiple populations of insulin receptor antibodies with different receptor binding and insulin-mimicking activities. Diabetes 33:301-304
11. Di Paolo S, Giorgino R 1991 Insulin resistance and hypoglycemia in a patient with systemic lupus erythematosus: description of antiinsulin receptor antibodies that enhance insulin binding and inhibit insulin action. J Clin Endocrinol Metab 73:650-657 (Pubitemid 21921921)
12. Vermeulen A, Verdonck L, Kaufman JM 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672 (Pubitemid 30645223)
13. Semple RK, Soos MA, Luan J, Mitchell CS, Wilson JC, Gurnell M, Cochran EK, Gorden P, Chatterjee VK, Wareham NJ, O'Rahilly S 2006 Elevated plasma adiponectin in humans with genetically defective insulin receptors. J Clin Endocrinol Metab 91:3219-3223 (Pubitemid 44271779)
14. Coll AP, Morganstein D, Jayne D, Soos MA, O'Rahilly S, Burke J 2005 Successful treatment of type B insulin resistance in a patient with otherwise quiescent systemic lupus erythematosus. Diabet Med 22:814-815 (Pubitemid 40805909)
15. Semple RK, Sleigh A, Murgatroyd PR, Adams CA, Bluck L, Jackson S, Vottero A, Kanabar D, Charlton-Menys V, Durrington P, Soos MA, Carpenter TA, Lomas DJ, Cochran EK, Gorden P, O'Rahilly S, Savage DB 2009 Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest 119:315-322
16. Semple RK, Halberg NH, Burling K, Soos MA, Schraw T, Luan J, Cochran EK, Dunger DB, Wareham NJ, Scherer PE, Gorden P, O'Rahilly S 2007 Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes 56:1712-1717 (Pubitemid 46842611)
17. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J 2002 Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360:57-58 (Pubitemid 34756495)
18. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800 (Pubitemid 28009567)
19. Bao S, Root C, Jagasia S 2007 Type B insulin resistance syndrome associated with systemic lupus erythematosus. Endocr Pract 13:51-55
20. Bloise W, Wajchenberg BL, Moncada VY, Marcus-Samuels B, Taylor SI 1989 Atypical antiinsulin receptor antibodies in a patient with type B insulin resistance and scleroderma. J Clin Endocrinol Metab 68:227-231 (Pubitemid 19028751)
21. Eriksson JW, Bremell T, Eliasson B, Fowelin J, Fredriksson L, Yu ZW 1998 Successful treatment with plasmapheresis, cyclophosphamide, and cyclosporin A in type B syndrome of insulin resistance. Case report. Diabetes Care 21:1217-1220 (Pubitemid 28365672)
22. Gehi A, Webb A, Nolte M, Davis Jr J 2003 Treatment of systemic lupus erythematosus-associated type B insulin resistance syndrome with cyclophosphamide and mycophenolate mofetil. Arthritis Rheum 48:1067-1070 (Pubitemid 36418249)
23. Kramer N, Rosenstein ED, Schneider G 1998 Refractory hyperglycemia complicating an evolving connective tissue disease: response to cyclosporine. J Rheumatol 25:816-818 (Pubitemid 28212400)
24. Page KA, Dejardin S, Kahn CR, Kulkarni RN, Herold KC, Inzucchi SE 2007 A patient with type B insulin resistance syndrome, responsive to immune therapy. Nat Clin Pract Endocrinol Metab 3:835-840 (Pubitemid 350145526)
25. Sims RE, Rushford FE, Huston DP, Cunningham GR 1987 Successful immunosuppressive therapy in a patient with autoantibodies to insulin receptors and immune complex glomerulonephritis. South Med J 80:903-906
26. Tran HA, Reeves GE 2009 Treatment of type B insulin resistance with immunoglobulin: novel use of an old therapy. Med J Aust 190:168
27. Coll AP, Thomas S, Mufti GJ 2004 Rituximab therapy for the type B syndrome of severe insulin resistance. N Engl J Med 350:310-311 (Pubitemid 38067651)